NAEUN HOSPITAL
Glaucoma treatment cost in South Korea for essential diagnostics like an ophthalmological investigation runs from Price on request to Price on request , while specialized surgery typically ranges from Price on request to Price on request . Prices depend on the surgical technique, clinic tier, and disease stage. Australians generally save 50–70% compared to local private healthcare rates. Seoul, Busan, and Incheon are the primary hubs for advanced eye care.
Typical Glaucoma Treatment Costs in South Korea
Bookimed Expert Insight: Patients with complex retinal issues should choose multidisciplinary centres like Severance Hospital, which is Joint Commission International (JCI) accredited. For those needing advanced vision correction alongside treatment, specialists like Dr. Lee Kwan Hoon have performed over 15,000 retinal procedures. Clinics like Seoul National University Bundang Hospital use the BESTcare system to prevent medical errors, making them ideal for patients prioritizing safety through digital integration.
| Republic of Korea | Thailand | Turkey | |
| Trabeculotomy | - | from AUD $2,089 | from AUD $2,089 |
| Laser trabeculoplasty | - | from AUD $1,184 | from AUD $696 |
No hidden fees – just official clinic prices. Pay at the clinic for Glaucoma treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Glaucoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Glaucoma treatment journey.
Dr. Sungwon Cho is the Director of Ophthalmology at Samsung Miracle Eye Clinic in Seoul. He is a certified ZEISS SMILE Excellent Surgeon focusing on vision correction. He has performed over 9,000 surgical procedures. Dr. Cho earned his degree from Boston University and trained at Korea University.
Dr. Chong Gi Von has helped over 500,000 patients restore their vision at BGN Eye Hospital. He is the Chief Director and a leading surgeon specializing in refractive and cataract surgery. Dr. Chong focuses on minimally invasive techniques to ensure rapid recovery and safety.
Dr. Jinchul Kim is the director of Samsung Miracle Eye Clinic in Seoul. He developed the Miracle Formula. This is the first lens power calculator designed for Asian biometric profiles. Dr. Kim specializes in SMILE, laser vision correction, and custom cataract surgery. He currently serves as a visiting professor at Samsung Seoul Hospital.
Dr. Yoonjung Jo is a board-certified ophthalmologist and Director at Samsung Miracle Eye Clinic in Seoul. She is a certified ZEISS SMILE Excellent Surgeon specializing in refractive vision correction. Her practice focuses on personalized astigmatism and vision repair using 1:1 surgical planning. Dr. Jo is a member of the American Academy of Ophthalmology (AAO).
In South Korea, glaucoma eye drops often cause conjunctival redness, stinging, and blurred vision. Local studies show these ocular surface issues are the most frequent. Reactions often intensify with multiple drops. Leading clinics such as Severance Hospital and SNUH provide diagnostic monitoring.
Bookimed Expert Insight: Korean ophthalmologists often prescribe preservative-free drops. They minimise the stinging frequently reported with multi-dose bottles. Clinics like Samsung Miracle Eye Clinic use 1:1 individualised planning. This approach helps identify the exact drop concentration that balances pressure control and patient comfort.
Patient Consensus: Patients note that dorzolamide drops can feel like opening eyes in the ocean. Many find that refrigerating drops or using preservative-free tears significantly reduces the sharp stinging sensation.
Patients typically follow a structured schedule in Korea to monitor intraocular pressure and optic nerve health. Expect the first check-up within 24 hours of surgery. Frequent visits occur every 1 to 3 weeks for the first 3 months. Stable cases then move to appointments every 3 to 6 months.
Bookimed Expert Insight: Korea's major centres like Seoul National University Hospital and Asan Medical Center use fully digital health systems to track long-term pressure trends. Experienced specialists like Dr Jinchul Kim, who trained at the Mayo Clinic, often recommend a 1-week stay in Korea. This covers the most critical early post-operative monitoring before patients fly back to Australia.
Patient Consensus: Patients in Korea find that check-ups are front-loaded in the first month. They often occur weekly before stretching to 3-monthly or annual reviews once eye pressure stays stable.
Normal-tension glaucoma is the most frequent form treated in South Korea. It accounts for approximately 94.4% of open-angle cases in the region. Specialists prioritise lowering intraocular pressure using prostaglandin analogue eye drops or laser therapies within JCI-accredited facilities.
Bookimed Expert Insight: Many Western countries focus on high-pressure glaucoma. However, Korean clinics specialise in normal-tension cases, where pressure appears typical. Specialists like Dr Jinchul Kim at Samsung Miracle Eye Clinic develop custom biometric formulas. These are specifically for Asian eye profiles to improve surgical accuracy.
Patient Consensus: Patients find that South Korean specialists prioritise daily eye drops to slow damage. They recommend asking if cases require single-drug or combination therapy early in the consultation.
In South Korea, prostaglandin analogue (PGA) eye drops are the primary first-line treatment for glaucoma. Specialists frequently prescribe latanoprost or bimatoprost to lower intraocular pressure. This method effectively manages normal-tension glaucoma, which is highly prevalent among Korean patients.
Bookimed Expert Insight: South Korea leads in treating normal-tension glaucoma, where eye pressure remains within typical ranges. Specialists such as Dr Jinchul Kim at Samsung Miracle Eye Clinic develop custom biometric formulas. These are specifically designed for Asian eye profiles. This level of specialisation leads to more accurate treatment planning than generic global protocols.
Patient Consensus: Patients note that eye drops like latanoprost are standard in Korea. However, many now discuss selective laser trabeculoplasty (SLT) early to avoid daily dosing. They emphasise confirming whether the condition is open-angle or narrow-angle before starting. Surgical needs differ significantly between types.
Advanced surgical techniques for glaucoma treatment are widely available in the Republic of Korea. Specialists use high-resolution OCT imaging and minimally invasive procedures like laser trabeculoplasty and trabeculotomy. Leading centres in Seoul and Incheon provide care at JCI-accredited facilities with high success rates.
Bookimed Expert Insight: While many Australian patients look for standard care, South Korean specialists like Dr Jinchul Kim developed the world's first IOL power calculation formula specifically for Asian eye profiles. This level of anatomical specialisation means surgical planning for glaucoma and related lens issues is more precise than generic global protocols.
Patient Consensus: Patients describe Korean glaucoma interventions as intensive hospital-style procedures compared to routine laser work. They highlight the remarkable efficiency and advanced technology available in Seoul, often noting the use of physical comfort aids during surgery.
Advanced glaucoma treatment in Korea combines high-resolution imaging with surgical interventions. These include trabeculectomy and shunt procedures. Specialist centres utilise OCT scans to monitor nerve damage precisely. Korean doctors often target lower pressure levels than Western standards. This protects sight from normal-tension glaucoma.
Bookimed Expert Insight: Korean ophthalmologists specialise in normal-tension glaucoma, which is common in Asian populations. Patients may still lose vision despite 'normal' eye pressure. So clinics like Samsung Miracle Eye Clinic use custom calculation programs for Asian biometric profiles. This tailors surgical targets specifically to an individual's unique eye structure.
Patient Consensus: Patients note that Korean clinics provide comprehensive medical booklets for Australian GPs. Treatment often includes multiple follow-up tests. These monitor eye pressure stability before patients fly home.
South Korea offers highly efficient glaucoma care featuring ultra-fast diagnostics and specialised surgeries. Clinics provide laser trabeculoplasty and trabeculotomy using precise mapping. Expert ophthalmologists often have international training. High-volume hospitals manage millions of outpatients, building deep surgical expertise for complex cases.
Bookimed Expert Insight: South Korea is a global hub for Asian-specific glaucoma research. Dr Jinchul Kim developed the world’s first IOL power calculation program. It specifically targets Asian biometric profiles. Patients benefit from this targeted approach. High-volume centres like Seoul National University Hospital serve 30,000 international patients annually. This massive scale means surgeons maintain peak proficiency in complex intraocular lens implantations.
Patient Consensus: Patients describe South Korean eye procedures as surprisingly swift and much cheaper than home. Many appreciate that treatment is often bundled with medication and thorough aftercare.
South Korea is a global leader in glaucoma research. It focuses on Minimally Invasive Glaucoma Surgery and innovative shunts. New 2025 options include the XEN 63 Gel Implant and the A-stream shunt. They provide controlled pressure management. These help patients who do not respond to traditional eye drops.
Bookimed Expert Insight: Korean clinics are uniquely positioned to treat Asian biometric profiles. Dr Jinchul Kim developed the Miracle Formula precisely for this reason. Patients benefit from this specialised IOL power calculation. It is more accurate for local ocular structures than Western models. This level of customisation leads to better surgical outcomes in complex glaucoma and cataract cases.
Patient Consensus: Patients note that Korean research into nerve regeneration and gene therapy is exciting. However, it remains in trial stages. Future cures are being developed. However, current care focuses on slowing progression. It does so through surgical shunts and specialised medication protocols.